Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Icotinib plus WBRT for NSCLC Brain Metastases
NCT01514877Phase 2Completed
- Sponsor
- Zhejiang Cancer Hospital
- Start
- Jan 2012
- Primary completion
- Jul 2014
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of icotinib in non-small cell lung cancer (NSCLC), sponsored by Zhejiang Cancer Hospital. Started Jan 2012; status: completed.
02
Drugs
icotinib
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT01514877.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01514877.